drug
Exosome-Based Vaccine
Phase 1updated 3mo agoby $CAPR CAPRICOR THERAPEUTICS, INC.
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Capricor soars on potential FDA review extension, filing amendmentsCapricor Therapeutics’ CEO Linda Marbán believes the FDA is willing to work with the biotech as the Aug. 22 deadline approaches for its Duchenne muscular dystrophy cell therapy deramiocel, with the…biospace · 3d ago
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that